Company information
- Ticker
- 4175
- Country
- Taiwan
- Sector
- Health Care
- Industry
- Biotech
MedFirst Business Summary
MedFirst Healthcare Services, Inc. (4175.TWO) operates a high-volume retail and service model centered on medical supplies and healthcare products across Taiwan and Mainland China. The company generates revenue primarily through transaction-based sales in its network of over 300 "MedFirst" branded stores, supplemented by hospital shopping mall management, prescription drug services, and medical laundry operations. Its primary business segments include Medical Care (diabetes, respiratory, and wound care), Health Care (beauty, oral hygiene, and daily essentials), and Biotech Health (functional foods and medicines). MedFirst holds a dominant market position as Taiwan’s leading hospital-adjacent medical retail chain, specializing in post-discharge and long-term home care solutions. It competes directly with Great Tree Pharmacy (6469.TWO), We Can Medicines (6929.TWO), and Norbel Baby (6419.TWO), distinguishing itself from broader retailers like President Chain Store (2912.TW) through a professional, medical-led service approach that integrates clinical expertise with retail distribution. Founded in 1990 by Chairman Chen Li-Ju, a former nurse at Linkou Chang-Gung Memorial Hospital, MedFirst is built on a pedigree of clinical expertise and patient-centric service. The current executive leadership team is anchored by Chen Li-Ju and General Manager (CEO) Tsai Te-Chung, supported by Vice President and Spokesman Wang Ding-Jui, who was elevated to his current role in early 2026 to drive operational scaling and digital transformation. The company’s ownership structure is characterized by strong institutional backing, with SaluMed Co., Ltd. and LEAD Investment Co., Ltd. serving as the largest shareholders, collectively holding over 50% of the equity. The board of directors is recognized for its professional diversity and strategic focus on the "membership economy," maintaining a leadership team that blends medical professional backgrounds with seasoned corporate governance to navigate the aging demographic trends in the Asia-Pacific region.